Foresite Capital Management IV’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.9M Hold
2,111,919
20.93% 2
2025
Q1
$23.3M Buy
+2,111,919
New +$23.3M 20.93% 2